openPR Logo
Press release

Roadside Drug Testing Devices Market Highlights On Evolution 2027

08-28-2020 12:34 PM CET | Health & Medicine

Press release from: Transparency Market Research

Roadside Drug Testing Devices Market Highlights On Evolution

Roadside Drug Testing Devices Market: Introduction

Transparency Market Research has published a new report titled, ‘Global Roadside Drug Testing Devices Market’. According to the report, the global roadside drug testing devices market was valued at US$ 652 Mn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027.

Read Report Overview - https://www.transparencymarketresearch.com/roadside-drug-testing-devices-market.html

Stringent Law Enforcement to Drive Adoption of Advanced Roadside Drug Testing Devices

Drug-impaired driving has emerged as a major public health issue. Alcohol and psychoactive drugs affect an individual’s ability to drive a motor vehicle safely. Increase in number of drug and alcohol abusers across the world presents significant opportunities for the test providers and manufacturers of drug abuse test products. According to the National Institute of Drug Abuse, alcohol, tobacco, and illicit drugs create an economic burden of nearly US$ 740 Bn in the U.S. in terms of related costs, lost work productivity, and healthcare.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76205

Technological advancements related to sample collection and efforts of manufacturers to create easy-to-use disposable test kits are expected to increase the demand for drug abuse testing products. Manufacturers focus on using samples other than urine such as sweat and hair, which are less embarrassing for individuals tested for drug abuse. Manufacturers also focus on development of rapid tests that provide faster results, are easy to use, and affordable compared to the tests conducted in laboratories.

Devices for Testing Alcohol Abuse to Witness High Demand

In terms of substance, the alcohol segment held major share of the global roadside drug testing devices market in 2018. The segment is projected to dominate the global market during the forecast period. The alcohol segment is anticipated to expand at a CAGR of ~4% from 2019 to 2027. Rise in consumption of alcohol and increase in incidence of driving under the influence of alcohol accelerate the growth of the global roadside drug testing devices market. Moreover, increase in approvals of roadside drug testing devices and rise in the impact of alcohol abuse on public health contribute to the growth of the global market.

Request for Analysis of COVID-19 Impact on Roadside Drug Testing Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76205

Breath Analyzers to Lead Global Market

Based on sample type, the others segment, which includes breath, hair, and blood, accounted for significant share of the global roadside drug testing devices market in 2018. The segment is expected to expand at a moderate CAGR during the forecast period. Breath is the most common sample used for the detection of alcohol. Alcohol is the most widely used substance of abuse among drivers. According to data provided by the European DRUID project, alcohol is used by 3.48% drivers, illicit drugs by 1.90%, medicinal drugs by 1.36%, drug-drug combination by 0.39%, and alcohol-drug combination by 0.37%. The saliva segment is likely to witness strong growth during the forecast period. Roadside oral fluid or saliva testing is primarily being used in several countries to detect the presence of drugs. Countries such as Germany, Belgium, France, and Australia use saliva testing for identification of individuals driving under the influence of drugs (DUID).

Roadside Drug Testing Devices Market: Prominent Regions

North America held major share of the global roadside drug testing devices market in 2018. The market in the region is driven by presence of key players, high prevalence of driving under the influence of alcohol & illicit drugs, and growth strategies adopted by market players, including product approvals and launch, mergers, and acquisitions. According to Centers for Disease Control and Prevention (CDC) estimates, around 20.5 million people in the U.S. were reported driving under the influence of alcohol in 2018. Europe held the second largest share of the global roadside drug testing devices market in 2018.

Growth of the roadside drug testing devices market in the region can be attributed to rise in cases of driving under the influence of alcohol and increase in government initiatives to control road accidents & fatalities in various countries in Europe. Asia Pacific accounted for significant share of the global roadside drug testing devices market in 2018. The market in the region is projected to grow at a rapid pace during the forecast period. According to various studies, alcohol consumption is rising across Asia Pacific.

Heavy episodic (binge) alcohol use has increased significantly in China, Thailand, Timor-Leste, and Vietnam. Rise in use of alcohol and other illicit drugs in the region is anticipated to drive the market in Asia Pacific during the forecast period. Moreover, implementation of strict driving laws in different countries in Asia Pacific can be attributed to the growth of the market in the region.

Buy Roadside Drug Testing Devices Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=76205<ype=S

Roadside Drug Testing Devices Market: Key Players

Key players focus on strengthening their positions in the global roadside drug testing devices market. Rise in road fatalities due to drug-impaired driving has led to adoption of strict laws and regulations in several countries. This presents lucrative opportunities to key players to increase their share in the roadside drug testing devices market. Manufacturers are adopting strategies such as acquisitions, collaborations, and distribution to increase share in the global roadside drug testing devices market.

In August 2019, Abbott and Intoximeters signed an agreement according to which, Intoximeters will market Abbott's SoToxa Mobile Test System (a handheld oral fluid roadside testing solution that rapidly and reliably detects recent drug use) along with its Alco-Sensor brand breath alcohol-testing products. This agreement will aid law enforcement agencies in their efforts to reduce the rate of drug driving, which has become a serious road safety issue.

Prominent players operating in the global roadside drug testing devices market are Drägerwerk AG & Co. KgaA, Abbott Laboratories, Oranoxis, Inc., CareHealth America, MAVAND Solutions GmbH, Pacific Data Systems Pty Ltd., Securetec, and UriTox, LLC.

More Trending Reports by Transparency Market Research –

Osteoporosis Drugs Market: http://www.prnewswire.com/news-releases/despite-several-factors-supporting-osteoporosis-drugs-market-patent-expiration-of-blockbuster-drugs-to-hamper-markets-progress-tmr-301019711.html

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Roadside Drug Testing Devices Market Highlights On Evolution 2027 here

News-ID: 2123634 • Views: 221

More Releases from Transparency Market Research

Biomedical Refrigerators and Freezers Market Insights by 2027
According to a new market report published by Transparency Market Research titled “Biomedical Refrigerators and Freezers Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027,” the global biomedical refrigerator and freezer market is expected to reach a value of US$ 7122.4 Mn by 2027. In terms of value, the market is estimated to expand at a CAGR of 4.5% during the forecast period from 2019 to 2027.
Construction Market Trends and Research Insights by 2027
Transparency Market Research delivers key insights on the global construction market. In terms of revenue, the construction market is estimated to expand at a CAGR of ~4% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in the construction market report. In the report, TMR predicts that the construction market would be largely driven by factors, such as rise in population and investments in
Microdisplay Market to rise at a CAGR of 22.3% by 2027 – TMR
According to a new research report on the global microdisplay market published by Transparency Market Research (TMR) the global microdisplay market is expected to reach value of US$ 5782.6 Mn by 2027, expanding at a CAGR of 22.3% from 2019 to 2027. According to the report, the global market is likely to continue to be influenced by a range of macroeconomic and market-specific factors in the next few years. In
Automotive Wiring Harness Market Research Insights by 2027
According to the report, the global automotive wiring harness market is projected to reach ~US$ 76 Bn by 2027, expanding at a CAGR of ~5% during the forecast period. Increasing GDP and technological advancements are major factors fueling the demand for automotive wiring harness market globally. The automotive wiring harness is undergoing an architectural revolution, owing to increase in incorporation of electronic components in vehicles, causing the weight of wiring

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning